publication . Article . 2018

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells

Mou D-C; Cai S-L; Peng J-R; Wang Y; Chen H-S; Pang X-W; Leng X-S; Chen W-F;
Open Access English
  • Published: 13 Nov 2018 Journal: British Journal of Cancer, volume 86, issue 1, pages 110-116 (issn: 0007-0920, eissn: 1532-1827, Copyright policy)
  • Publisher: Nature Publishing Group
The members of MAGE gene family are highly expressed in human hepatocellular carcinoma (HCC). In the present study, we tested the tumour-specific MAGE-1 and MAGE-3 transcripts in the peripheral blood of HCC patients by nested RT–PCR to detect the circulating tumour cells and evaluate their potential clinical implication. Of 30 HCC patients, the positive rate of MAGE-1 and MAGE-3 transcripts was 43.3% (13 out of 30) and 33.3% (10 out of 30) in PBMC samples, whilst the positive rate was 70% (21 out of 30) and 53.3% (16 out of 30) in the resected HCC tissue samples, respectively. The positivity for at least one MAGE gene transcript was 63.3% (19 out of 30) in PBMC ...
Medical Subject Headings: neoplasmsendocrine system
free text keywords: Molecular and Cellular Pathology, circulating tumour cells, hepatocellular carcinoma, MAGE transcripts, nested polymerase chain reaction, tumour-specific marker, Cancer Research, Oncology, Gene transcript, Messenger RNA, Polymerase chain reaction, law.invention, law, medicine.disease, medicine, business.industry, business, Peripheral blood mononuclear cell, Immunology, Nucleotidyltransferase, Metastasis, Pathology, medicine.medical_specialty, Cancer
Related Organizations
33 references, page 1 of 3

Brossart, P, Keilholz, U, Willhauck, M, Scheibenbogen, C, Mohler, T, Hunstein, W. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol. 1993; 101: 887-889 [OpenAIRE] [PubMed]

Cai, SL, Chen, HS, Wang, Y, Zhao, HR, Peng, JR, Pang, XW, Gong, SY, Zhu, JY, Cong, X, Wang, Y, Rui, JA, Leng, XS, Du, RY, Chen, WF. Expression of MAGE-1 gene in hepatocellular carcinoma. Natl Med J China. 1999; 79: 668-672

Cai, SL, Zhao, HT, Leng, XS, Cheng, JH, Gong, SY, Peng, JR, Cong, X, Wang, Y, Rui, JA, Hui, YZ, Du, RY, Chen, WF. Melanoma antigen-3 expression in human hepatocellular carcinoma. Chin J Surg. 2000; 38: 693-696 [OpenAIRE]

Chen, CH, Huang, GT, Lee, HS, Yang, PM, Yan, MD, Chen, DS, Sheu, JC. High frequency of expression of MAGE genes in human hepatocellular carcinoma. Liver. 1999; 19: 110-114 [PubMed]

Chou, HC, Sheu, JC, Huang, GT, Wang, JT, Chen, DS. Albumin messenger RNA is not specific for circulating hepatoma cells. Gastroenterology. 1994; 107: 630-631 [OpenAIRE] [PubMed]

Dall, P, Heider, KH, Sinn, HP, Skroch-Angel, P, Adolf, G, Kaufmann, M, Herrlich, P, Ponta, H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer. 1995; 60: 471-477 [OpenAIRE] [PubMed]

De Plaen, E, Arden, K, Traversari, C, Gaforio, JJ, Szikora, JP, De Smet, C, Brasseur, F, van der Bruggen, P, Lethe, B, Lurquin, C, Brasseur, R, Chomez, P, De Backer, O, Cavenee, W, Boon, T. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 1994; 40: 360-369 [PubMed]

Foss, AJ, Guille, MJ, Occleston, NL, Hykin, PG, Hungerford, JL, Lightman, S. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer. 1995; 72: 155-159 [OpenAIRE] [PubMed]

Hillaire, S, Barbu, V, Boucher, E, Moukhtar, M, Poupon, R. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocelular carcinoma. Gastroenterology. 1994; 106: 239-242 [PubMed]

Hoon, DS, Wang, Y, Dale, PS, Conrad, AJ, Schmid, P, Garrison, D, Kuo, C, Foshag, LJ, Nizze, AJ, Morton, DL. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol. 1995; 13: 2109-2116 [OpenAIRE] [PubMed]

Israeli, RS, Miller, WH, Su, SL, Powell, CT, Fair, WR, Samadi, DS, Huryk, RF, DeBlasio, A, Edwards, ET, Wise, GJ, Heston, WDW. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumour cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res. 1994; 54: 6306-6310 [PubMed]

Israeli RS Miller WH Jr Su SL Samadi DS Powell CT Heston WD Wise GJ Fair WR Sensitive detection of prostatic hematogenous tumour cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction J Urol 1995 53 73 77(3 Pt 1)

Jiang, SY, Shyu, RY, Huang, MF, Tang, HS, Young, TH, Roffler, SR, Chiou, YS, Yeh, MY. Detection of alphafetoprotein expressing cells in the blood of patients with hepatoma and hepatitis. Br J Cancer. 1997; 75: 928-933 [OpenAIRE] [PubMed]

Kar, S, Carr, BI. Detection of liver cells in peripheral blood of patients with advanced hepatocelular carcinoma. Hepatology. 1995; 21: 403-407 [OpenAIRE] [PubMed]

Komeda, T, Fukuda, Y, Sando, T, Kita, R, Furukawa, M, Nishida, N, Amenomori, M, Nakao, K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer. 1995; 75: 2214-2219 [OpenAIRE] [PubMed]

33 references, page 1 of 3
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2018

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells

Mou D-C; Cai S-L; Peng J-R; Wang Y; Chen H-S; Pang X-W; Leng X-S; Chen W-F;